ISpecimen Shares Rise 8%; Break Downward Trend

Shares of human biospecimens online platform iSpecimen Inc. (ISPC) are up 8 percent on Tuesday's trading, thus breaking the downward movement since the past few days.

iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, tissues, and living cells for their research, with the available biospecimens. It began trading on the Nasdaq on June 17.

Currently at $8.66, the stock has traded between $4.75 and $28.78 during the past 52 weeks.

For comments and feedback contact: editorial@rttnews.com

Business News

Looking to Invest in the Best Biotech Stocks? Subscribe to RTT Biotech Investor.
Follow RTT